Application of nano compounds for the prevention, diagnosis, and treatment of SARS-coronavirus: A review en en Coronavirus disease, also called COVID-19, a universal health concern, has a?ected more than 200 countries after its declaration as a pandemic on 11 March 2020 by the World Health Organization, WHO. COVID-19 results due to SARS-CoV-2 entrance into the epithelial cells of the human’s lung. Recently, nanotechnology has turned to be a great promising method used in the medical feld regarding viruses. By mitigating infection, nanotechnology plays an important part in the diagnostics, prevention, and therapeutic approaches for controlling COVID-19. The development of nanomaterials for viral disease is based on preventive measures and disinfectants, diagnostic devices, and therapeutic drugs or vaccines to transfer antiviral drugs into the human body. Being at the same scale as viruses, nanoparticles can replicate the functional and structural properties of viruses, and nanomaterials can be the best substitute for developing vaccines. A broad range of nanostructures, including gold, silver, zinc, graphene, carbon, liposomes, and polymeric compounds, have antiviral activity and can be employed in vaccine development or inactivation of the virus. 230 246 Ahmed Hamad Saleh Biology Department University of Kirkuk Iraq info@jourcc.com Dharmendra Kumar Department of Pharmacy Galgotias University India info@jourcc.com Ivo Sirakov Department of Medical Microbiology Medical University of Sofia Bulgaria info@jourcc.com Parisa Shafiee Catalyst and Nano Material Research Laboratory (CNMRL) Iran University of Science and Technology Iran Parisashafiee603@gmail.com Mehrnoosh Arefian Department of Biochemistry Islamic Azad University, Falavarjan Branch Iran info@jourcc.com SARS-coronavirus Nanocompounds COVID-19 Nanotechnology Article4.pdf [1] W.H. Organization, World Health Organization coronavirus disease (COVID-19) dashboard, World Health Organization (2020). ## [2] M.A. Shereen, S. Khan, A. Kazmi, N. Bashir, R. Siddique, COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, Journal of advanced research 24 (2020) 91. ## [3] F. Li, Structure, function, and evolution of coronavirus spike proteins, Annual review of virology 3 (2016) 237-261. ## [4] E. Serag, M. El-Zeftawy, Environmental aspect and applications of nanotechnology to eliminate COVID-19 epidemiology risk, Nanotechnology for Environmental Engineering 6(1) (2021) 1-17. ## [5] P. Singh, D. Singh, P. Sa, P. Mohapatra, A. Khuntia, S. K Sahoo, Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation, Nanomedicine 16(14) (2021) 1219-1235. ## [6] S. Boopathi, A.B. Poma, P. Kolandaivel, Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment, Journal of Biomolecular Structure and Dynamics 39(9) (2021) 3409-3418. ## [7] K. Sheikhi, H. Shirzadfar, M. Sheikhi, A review on novel coronavirus (Covid-19): symp-toms, transmission and diagnosis tests, Research in Infectious Diseases and Tropical Medicine 2(1) (2020) 1-8. ## [8] L. Singh, H.G. Kruger, G.E. Maguire, T. Govender, R. Parboosing, The role of nanotechnology in the treatment of viral infections, Therapeutic advances in infectious disease 4(4) (2017) 105-131. ## [9] D. Yang, Application of Nanotechnology in the COVID-19 Pandemic, International Journal of Nanomedicine 16 (2021) 623. ## [10] H.R. Rezaie, H.B. Rizi, M.M.R. Khamseh, A. Öchsner, Primary Information About Biomaterials, A Review on Dental Materials, Springer2020, pp. 1-30. ## [11] M. Radmansouri, E. Bahmani, E. Sarikhani, K. Rahmani, F. Sharifianjazi, M. Irani, Doxorubicin hydrochloride-Loaded electrospun chitosan/cobalt fer-rite/titanium oxide nanofibers for hyperthermic tumor cell treatment and controlled drug release, International journal of biological macromolecules 116 (2018) 378-384. ## [12] S.P. Adhikari, S. Meng, Y.-J. Wu, Y.-P. Mao, R.-X. Ye, Q.-Z. Wang, C. Sun, S. Sylvia, S. Rozelle, H. Raat, Epidemiology, causes, clinical manifesta-tion and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak peri-od: a scoping review, Infectious diseases of poverty 9(1) (2020) 1-12. ## [13] B. Saawarn, S. Hait, Occurrence, fate and removal of SARS-CoV-2 in wastewater: Current knowledge and future perspectives, Journal of Envi-ronmental Chemical Engineering 9(1) (2021) 104870. ## [14] Y. Yang, W. Shang, X. Rao, Facing the COVID‐19 outbreak: What should we know and what could we do?, Journal of medical virology (2020). ## [15] D. Wu, T. Wu, Q. Liu, Z. Yang, The SARS-CoV-2 outbreak: what we know, International Journal of Infectious Diseases 94 (2020) 44-48. ## [16] M. Pal, G. Berhanu, C. Desalegn, V. Kandi, Severe acute respiratory syn-drome coronavirus-2 (SARS-CoV-2): an update, Cureus 12(3) (2020). ## [17] L. Mousavizadeh, S. Ghasemi, Genotype and phenotype of COVID-19: Their roles in pathogenesis, Journal of Microbiology, Immunology and Infection 54(2) (2021) 159-163. ## [18] A.D. Elmezayen, A. Al-Obaidi, A.T. Şahin, K. Yelekçi, Drug re-purposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes, Journal of Biomolecular Structure and Dynamics 39(8) (2021) 2980-2992. ## [19] J.S. Mani, J.B. Johnson, J.C. Steel, D.A. Broszczak, P.M. Neilsen, K.B. Walsh, M. Naiker, Natural product-derived phytochemicals as potential agents against coronaviruses: A review, Virus research 284 (2020) 197989. ## [20] M.K. Gupta, S. Vemula, R. Donde, G. Gouda, L. Behera, R. Vadde, In-silico approaches to detect inhibi-tors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel, Journal of Bi-omolecular Structure and Dynamics 39(7) (2021) 2617-2627. ## [21] R.J. Khan, R.K. Jha, G.M. Amera, M. Jain, E. Singh, A. Pathak, R.P. Singh, J. Muthukumaran, A.K. Singh, Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyl-transferase, Journal of Biomolecular Structure and Dynamics 39(8) (2021) 2679-2692. ## [22] S.A. Khan, K. Zia, S. Ashraf, R. Uddin, Z. Ul-Haq, Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach, Journal of Biomolecular Structure and Dynamics 39(7) (2021) 2607-2616. ## [23] T. Pillaiyar, M. Manickam, V. Namasivayam, Y. Hayashi, S.-H. Jung, An overview of severe acute respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy, Journal of medicinal chemistry 59(14) (2016) 6595-6628. ## [24] P. Sarma, N. Shek-har, M. Prajapat, P. Avti, H. Kaur, S. Kumar, S. Singh, H. Kumar, A. Prakash, D.P. Dhibar, In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain), Jour-nal of Biomolecular Structure and Dynamics 39(8) (2021) 2724-2732. ## [25] M. Pal, G. Berhanu, C. De-salegn, V. Kandi, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update, Cureus 12(3) (2020) e7423-e7423. ## [26] I.M. Artika, A.K. Dewantari, A. Wiyatno, Molecular biology of corona-viruses: current knowledge, Heliyon 6(8) (2020) e04743. ## [27] I. Astuti, Ysrafil, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response, Diabetes Metab Syndr 14(4) (2020) 407-412. ## [28] S.K. Saxena, S. Kumar, P. Baxi, N. Srivastava, B. Puri, R. Ratho, Chasing COVID-19 through SARS-CoV-2 spike glycoprotein, Springer, 2020, pp. 1-9. ## [29] Q. Zhang, R. Xiang, S. Huo, Y. Zhou, S. Jiang, Q. Wang, F. Yu, Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy, Signal Transduction and Targeted Therapy 6(1) (2021) 233. ## [30] P. Zhou, X.-L. Yang, X.-G. Wang, B. Hu, L. Zhang, W. Zhang, H.-R. Si, Y. Zhu, B. Li, C.-L. Huang, A pneumonia out-break associated with a new coronavirus of probable bat origin, nature 579(7798) (2020) 270-273. ## [31] J. Shang, G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach, F. Li, Structural basis of receptor recognition by SARS-CoV-2, Nature 581(7807) (2020) 221-224. ## [32] G. Lu, Y. Hu, Q. Wang, J. Qi, F. Gao, Y. Li, Y. Zhang, W. Zhang, Y. Yuan, J. Bao, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature 500(7461) (2013) 227-231. ## [33] V. Chaudhary, A. Royal, M. Chavali, S.K. Yadav, Advancements in research and development to combat COVID-19 using nanotechnology, Nanotechnology for Environmental Engineering 6(1) (2021) 8. ## [34] Y. Rasmi, K.S. Saloua, M. Nemati, J.R. Choi, Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment, Nanomateri-als 11(7) (2021) 1788. ## [35] S. Al-Halifa, L. Gauthier, D. Arpin, S. Bourgault, D. Archambault, Nanoparti-cle-based vaccines against respiratory viruses, Frontiers in immunology 10 (2019) 22. ## [36] S. Priyadarsini, S. Mukherjee, M. Mishra, Nanoparticles used in dentistry: A review, Journal of oral biology and craniofacial research 8(1) (2018) 58-67. ## [37] F. Vahedifard, K. Chakravarthy, Nanomedicine for COVID-19: The role of nanotechnology in the treatment and diagnosis of COVID-19, Emergent materials (2021) 1-25. ## [38] L. Yang, W. Li, M. Kirberger, W. Liao, J. Ren, Design of nanomaterial based systems for novel vaccine devel-opment, Biomaterials science 4(5) (2016) 785-802. ## [39] Y. Katayama, T. Ohgi, Y. Mitoma, E. Hifumi, N.J.A. Egashira, b. chemistry, Detection of influenza virus by a biosensor based on the method combining electrochemiluminescence on binary SAMs modified Au electrode with an immunoliposome encapsulating Ru (II) complex, 408(22) (2016) 5963-5971. ## [40] A. Mokhtarzadeh, M.J.I. Bouzari, Detection of the fre-quency of the novel TT virus by PCR and its role in the induction of hepatic injuries in blood donors in West Azarbaijan, Iran, 5 (2009) 25-31. ## [41] A. Mokhtarzadeh, R. Eivazzadeh-Keihan, P. Pashazadeh, M. Hejazi, N. Gharaatifar, M. Hasanzadeh, B. Baradaran, M. de la Guardia, Nanomaterial-based biosensors for detection of pathogenic virus, TrAC Trends in Analytical Chemistry 97 (2017) 445-457. ## [42] D.S. Chauhan, R. Pra-sad, R. Srivastava, M. Jaggi, S.C. Chauhan, M.M. Yallapu, Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2, Bioconjugate Chemistry 31(9) (2020) 2021-2045. ## [43] Y.-F. Tu, C.-S. Chien, A.A. Yarmishyn, Y.-Y. Lin, Y.-H. Luo, Y.-T. Lin, W.-Y. Lai, D.-M. Yang, S.-J. Chou, Y.-P. Yang, A review of SARS-CoV-2 and the ongoing clinical trials, International journal of molecular sciences 21(7) (2020) 2657. ## [44] T. Arun, S.K. Verma, P.K. Panda, R.J. Joseyphus, E. Jha, A. Akbari-Fakhrabadi, P. Sengupta, D. Ray, V. Benitha, K.J.M.S. Jeyasubramanyan, E. C, Facile synthesized novel hybrid graphene oxide/cobalt ferrite magnetic nanoparticles based surface coating material inhibit bac-terial secretion pathway for antibacterial effect, 104 (2019) 109932. ## [45] S.K. Verma, E. Jha, P.K. Panda, J.K. Das, A. Thirumurugan, M. Suar, S.J.N. Parashar, Molecular aspects of core-shell intrinsic defect induced enhanced antibacterial activity of ZnO nanocrystals, 13(1) (2018) 43-68. ## [46] B.K. Das, S.K. Verma, T. Das, P.K. Panda, K. Parashar, M. Suar, S.J.C.-b.i. Parashar, Altered electrical properties with controlled cop-per doping in ZnO nanoparticles infers their cytotoxicity in macrophages by ROS induction and apoptosis, 297 (2019) 141-154. ## [47] P. Kumari, P.K. Panda, E. Jha, N. Pramanik, K. Nisha, K. Kumari, N. Soni, M.A. Mal-lick, S.K.J.N. Verma, Molecular insight to in vitro biocompatibility of phytofabricated copper oxide nanopar-ticles with human embryonic kidney cells, 13(19) (2018) 2415-2433. ## [48] S.S. Jeremiah, K. Miyakawa, T. Morita, Y. Yamaoka, A.J.B. Ryo, b.r. communications, Potent antiviral effect of silver nanoparticles on SARS-CoV-2, 533(1) (2020) 195-200. ## [49] Z. Zhao, H. Cui, W. Song, X. Ru, W. Zhou, X.J.B. Yu, A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2, (2020). ## [50] T.T.S. Lew, K.M.M. Aung, S.Y. Ow, S.N. Amrun, L. Sutarlie, L.F. Ng, X.J.A.n. Su, Epitope-Functionalized Gold Nanoparticles for Rapid and Selective Detection of SARS-CoV-2 IgG Antibodies, (2021). ## [51] M. Soloviev, G. Siligardi, D. Roccatano, E.J.J.o.C. Ferrari, I. Science, Modelling the adsorption of proteins to nanoparticles at the solid-liquid interface, (2021). ## [52] F. De Maio, V. Palmieri, G. Babini, A. Augello, I. Palucci, G. Perini, A. Salustri, P. Spilman, M. De Spirito, M.J.I. Sanguinetti, Graphene nanoplatelet and Graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2, 24(7) (2021) 102788. ## [53] F. Zhang, Z. Wang, M.G. Vijver, W.J.J.E. Peijnenburg, e. safety, Probing nano-QSAR to assess the interactions between carbon nanoparticles and a SARS-CoV-2 RNA fragment, 219 (2021) 112357. ## [54] J.N. Wankar, V.K. Chaturvedi, C. Bohara, M.P. Singh, R.A.J.F.i.N. Bohara, Role of Nanomed-icine in Management and Prevention of COVID-19, 2 (2020) 8. ## [55] M. Khanal, T. Vausselin, A. Barras, O. Bande, K. Turcheniuk, M. Benazza, V. Zaitsev, C.M. Teodorescu, R. Boukherroub, A. Siriwardena, J. Dubu-isson, S. Szunerits, Phenylboronic-acid-modified nanoparticles: potential antiviral therapeutics, ACS applied materials and interfaces 5(23) (2013) 12488-98. ## [56] D. Kumar, K. Kumari, A. Jayaraj, V. Kumar, R.V. Kumar, S.K. Dass, R. Chandra, P. Singh, Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures, Journal of Biomolecular Struc-ture and Dynamics 39(7) (2021) 2659-2672. ## [57] H. Khalilpour, P. Shafiee, A. Darbandi, M. Yusuf, S. Mahmoudi, Z.M. Goudarzi, S. Mirzamohammadi, Application of Polyoxometalate-based composites for sen-sor systems: A review, Journal of Composites and Compounds 3(7) (2021) 129-139. ## [58] K. O’Dowd, K.M. Nair, P. Forouzandeh, S. Mathew, J. Grant, R. Moran, J. Bartlett, J. Bird, S.C. Pillai, Face masks and respira-tors in the fight against the COVID-19 pandemic: A review of current materials, advances and future perspec-tives, Materials 13(15) (2020) 3363. ## [59] D. Aydemir, N.N. Ulusu, Correspondence: Angiotensin-converting enzyme 2 coated nanoparticles containing respiratory masks, chewing gums and nasal filters may be used for protection against COVID-19 infection, Travel medicine and infectious disease 37 (2020) 101697. ## [60] S.P. Varahachalam, B. Lahooti, M. Chamaneh, S. Bagchi, T. Chhibber, K. Morris, J.F. Bolanos, N.-Y. Kim, A. Kaushik, Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects, International journal of nanomedicine 16 (2021) 539. ## [61] L.A. Dykman, Gold nanoparticles for preparation of antibod-ies and vaccines against infectious diseases, Expert Rev Vaccines 19(5) (2020) 465-477. ## [62] H.-W. Chen, C.-Y. Huang, S.-Y. Lin, Z.-S. Fang, C.-H. Hsu, J.-C. Lin, Y.-I. Chen, B.-Y. Yao, C.-M.J.J.B. Hu, Synthetic vi-rus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection, 106 (2016) 111-118. ## [63] H. Sekimukai, N. Iwata‐Yoshikawa, S. Fukushi, H. Tani, M. Kataoka, T. Suzuki, H. Hasegawa, K. Niikura, K. Arai, N. Nagata, Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs, Microbiology and immunology 64(1) (2020) 33-51. ## [64] N.H. Abd Ellah, S.F. Gad, K. Muhammad, G. E Batiha, H.F.J.N. Hetta, Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19, 15(21) (2020) 2085-2102. ## [65] L.M. Marques Neto, A. Kipnis, A.P.J.F.i.i. Junqueira-Kipnis, Role of metal-lic nanoparticles in vaccinology: implications for infectious disease vaccine development, 8 (2017) 239. ## [66] Q.-Y. Cai, S.H. Kim, K.S. Choi, S.Y. Kim, S.J. Byun, K.W. Kim, S.H. Park, S.K. Juhng, K.-H.J.I.r. Yoon, Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice, 42(12) (2007) 797-806. ## [67] A.K. Lytton‐Jean, R. Langer, D.G.J.S. Anderson, Five years of siRNA delivery: spot-light on gold nanoparticles, 7(14) (2011) 1932-1937. ## [68] X. Huang, M. Li, Y. Xu, J. Zhang, X. Meng, X. An, L. Sun, L. Guo, X. Shan, J.J.A.a.m. Ge, interfaces, Novel gold nanorod-based HR1 peptide inhibitor for Middle East respiratory syndrome coronavirus, 11(22) (2019) 19799-19807. ## [69] R. Itani, M. Tobaiqy, A.J.T. Al Faraj, Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients, 10(13) (2020) 5932. ## [70] J. Manso, M.L. Mena, P. Yanez-Sedeno, J.M.J.A.b. Pingarrón, Bienzyme amperometric biosensor using gold nanoparticle-modified electrodes for the determination of inulin in foods, 375(2) (2008) 345-353. ## [71] R. Cui, H. Huang, Z. Yin, D. Gao, J.-J.J.B. Zhu, Bioelectronics, Horseradish peroxidase-functionalized gold nanoparticle label for amplified immunoanalysis based on gold nanoparti-cles/carbon nanotubes hybrids modified biosensor, 23(11) (2008) 1666-1673. ## [72] Y. Huang, T. Xu, W. Wang, Y. Wen, K. Li, L. Qian, X. Zhang, G. Liu, Lateral flow biosensors based on the use of micro- and na-nomaterials: a review on recent developments, Mikrochimica acta 187(1) (2019) 70. ## [73] J.J. Mock, D.R. Smith, S.J.N.l. Schultz, Local refractive index dependence of plasmon resonance spectra from individual na-noparticles, 3(4) (2003) 485-491. ## [74] J.C. Huang, Y.-F. Chang, K.-H. Chen, L.-C. Su, C.-W. Lee, C.-C. Chen, Y.-M.A. Chen, C. Chou, Detection of severe acute respiratory syndrome (SARS) coronavirus nucle-ocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor, Biosensors and Bioelectronics 25(2) (2009) 320-325. ## [75] L.A. Layqah, S. Eissa, An electrochemical im-munosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes, Microchimica Acta 186(4) (2019) 224. ## [76] E.M. Abed, S.M. Ho-seini-Alfatemi, H. Sabati, M.A.K. Gaskarei, K. Delpasand, M.J.J.o.C.B.R. Ghasemi, Use of nanotechnology in the diagnosis and treatment of coronavirus, (2021). ## [77] Y.V. Liu, M.J. Massare, D.L. Barnard, T. Kort, M. Nathan, L. Wang, G. Smith, Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glyco-protein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV, Vaccine 29(38) (2011) 6606-6613. ## [78] C. Poon, A.A.J.N.E. Patel, Organic and inorganic nanoparticle vaccines for prevention of infectious diseases, 1(1) (2020) 012001. ## [79] B.-K. Jung, Y.K. Lee, J. Hong, H. Ghandehari, C.-O.J.A.n. Yun, Mild hyperthermia induced by gold nanorod-mediated plasmonic photothermal therapy enhances transduction and replication of oncolytic adenoviral gene delivery, 10(11) (2016) 10533-10543. ## [80] S. Ghosh, E. Mostafavi, A. Vernet-Crua, T.J.J.N.M.N.D.j. Webster, Nanomateri-al Approaches for the Prevention, Diagnosis and Treatment of COVID-19: A Paradigm Shift, 280 (2020) 2. ## [81] C. Huang, T. Wen, F.-J. Shi, X.-Y. Zeng, Y.-J. Jiao, Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay, ACS Omega 5(21) (2020) 12550-12556. ## [82] S. Kumar, C. Kempinski, X. Zhuang, A. Norris, S. Mafu, J. Zi, S.A. Bell, S.E. Nybo, S.E. Kinison, Z. Jiang, S. Goklany, K.B. Linscott, X. Chen, Q. Jia, S.D. Brown, J.L. Bowman, P.C. Babbitt, R.J. Peters, F. Chen, J. Chappell, Molecular Diversity of Terpene Synthases in the Liverwort Marchantia polymor-pha The Plant Cell 28(10) (2016) 2632-2650. ## [83] M.C. Sportelli, M. Izzi, E.A. Kukushkina, S.I. Hossain, R.A. Picca, N. Ditaranto, N. Cioffi, Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?, 10(4) (2020) 802. ## [84] C. Balagna, S. Perero, E. Percivalle, E.V. Nepita, M. Ferraris, Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating, Open Ce-ramics 1 (2020) 100006. ## [85] J. Daraei, Production and characterization of PCL (Polycaprolactone) coated TCP/nanoBG composite scaffolds by sponge foam method for orthopedic applications, Journal of Composites and Compounds 2(2) (2020) 44-49. ## [86] E.V.R. Campos, A.E.S. Pereira, J.L. de Oliveira, L.B. Carvalho, M. Guilger-Casagrande, R. de Lima, L.F. Fraceto, How can nanotechnology help to combat COVID-19? Opportu-nities and urgent need, Journal of Nanobiotechnology 18(1) (2020) 125. ## [87] S. Bhattacharjee, R. Joshi, A.A. Chughtai, C.R. Macintyre, Graphene Modified Multifunctional Personal Protective Clothing, 6(21) (2019) 1900622. ## [88] K. Shirvanimoghaddam, M.K. Akbari, R. Yadav, A.K. Al-Tamimi, M. Naebe, Fight against COVID-19: The case of antiviral surfaces, APL Materials 9(3) (2021) 031112. ## [89] S. Basak, G.J.N.-S. Packirisamy, Nano-Objects, Nano-based antiviral coatings to combat viral infections, 24 (2020) 100620. ## [90] M. Rai, S. Bonde, A. Yadav, A. Bhowmik, S. Rathod, P. Ingle, A. Gade, Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations, 13(7) (2021) 1224. ## [91] M. Maywald, I. Wessels, L.J.I.j.o.m.s. Rink, Zinc signals and immunity, 18(10) (2017) 2222. ## [92] D. Beyersmann, H.J.B. Haase, Functions of zinc in signaling, proliferation and differentiation of mammalian cells, 14(3) (2001) 331-341. ## [93] F. Niazvand, A. Cheshmi, M. Zand, R. NasrAzadani, B. Kumari, A. Raza, S. Nasibi, An overview of the development of composites containing Mg and Zn for drug delivery, Journal of Composites and Com-pounds 2(5) (2020) 193-204. ## [94] A. Pormohammad, N.K. Monych, R.J. Turner, Zinc and SARS CoV 2: A molecular modeling study of Zn interactions with RNA dependent RNA polymerase and 3C like proteinase enzymes, Int J Mol Med 47(1) (2021) 326-334. ## [95] S.A. Read, S. Obeid, C. Ahlenstiel, G.J.A.i.n. Ahlen-stiel, The role of zinc in antiviral immunity, 10(4) (2019) 696-710. ## [96] A.J. Te Velthuis, S.H. van den Worm, A.C. Sims, R.S. Baric, E.J. Snijder, M.J.J.P.p. van Hemert, Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, 6(11) (2010) e1001176. ## [97] C.-C. Lee, C.-J. Kuo, M.-F. Hsu, P.-H. Liang, J.-M. Fang, J.-J. Shie, A.H.-J.J.F.l. Wang, Structural basis of mercury-and zinc-conjugated complexes as SARS-CoV 3C-like protease in-hibitors, 581(28) (2007) 5454-5458. ## [98] A. Pormohammad, N.K. Monych, R.J. Turner, Zinc and SARS CoV 2: A molecular modeling study of Zn interactions with RNA dependent RNA polymerase and 3C like proteinase enzymes, International journal of molecular medicine 47(1) (2021) 326-334. ## [99] P. Bonaventura, G. Benedetti, F. Albarède, P.J.A.r. Miossec, Zinc and its role in immunity and inflammation, 14(4) (2015) 277-285. ## [100] H.H. Sandstead, A.S.J.A.j.o.p.h. Prasad, Zinc intake and resistance to H1N1 influenza, 100(6) (2010) 970-971. ## [101] K. Wu, R. Saha, D. Su, V.D. Krishna, J. Liu, M.C.-J. Cheeran, J.-P.J.A.A.N.M. Wang, Magnetic-nanosensor-based virus and pathogen detection strategies before and during covid-19, 3(10) (2020) 9560-9580. ## [102] M.-H. Lin, D.C. Moses, C.-H. Hsieh, S.-C. Cheng, Y.-H. Chen, C.-Y. Sun, C.-Y.J.A.r. Chou, Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via dif-ferent modes, 150 (2018) 155-163. ## [103] H. Zhang, J.M. Penninger, Y. Li, N. Zhong, A.S.J.I.c.m. Slutsky, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, 46(4) (2020) 586-590. ## [104] Y. Yan, H. Tao, J. He, S.-Y. Huang, The HDOCK server for integrated protein–protein docking, Nature protocols 15(5) (2020) 1829-1852. ## [105] D. Wrapp, N. Wang, K.S. Corbett, J.A. Goldsmith, C.-L. Hsieh, O. Abiona, B.S. Graham, J.S. McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 367(6483) (2020) 1260-1263. ## [106] R. Speth, E. Carrera, M. Jean‐Baptiste, A. Joachim, A.J.T.F.j. Linares, Concentration‐dependent effects of zinc on angio-tensin‐converting enzyme‐2 activity (1067.4), 28 (2014) 1067.4. ## [107] A.V. Skalny, L. Rink, O.P. Ajsuva-kova, M. Aschner, V.A. Gritsenko, S.I. Alekseenko, A.A. Svistunov, D. Petrakis, D.A. Spandidos, J.J.I.j.o.m.m. Aaseth, Zinc and respiratory tract infections: Perspectives for COVID 19, 46(1) (2020) 17-26. ## [108] E. Laurini, D. Marson, S. Aulic, A. Fermeglia, S. Pricl, Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence, ACS nano 15(4) (2021) 6929-6948. ## [109] L.A. Pittet, L. Hall-Stoodley, M.R. Rutkowski, A.G.J.A.j.o.r.c. Harm-sen, m. biology, Influenza virus infection decreases tracheal mucociliary velocity and clearance of Strepto-coccus pneumoniae, 42(4) (2010) 450-460. ## [110] A. Darma, I.G.M.R.G. Ranuh, W. Merbawani, R.A. Setyoningrum, B. Hidajat, S.N. Hidayati, A. Endaryanto, S.M.J.T.I.B.J. Sudarmo, Zinc supplementation effect on the bronchial cilia length, the number of cilia, and the number of intact bronchial cell in zinc deficiency rats, 12(1) (2020) 78-84. ## [111] K. Berg, G. Bolt, H. Andersen, T.C.J.J.o.I. Owen, C. Research, Zinc potenti-ates the antiviral action of human IFN-α tenfold, 21(7) (2001) 471-474. ## [112] D. Khera, S. Singh, P. Puro-hit, P. Sharma, K.J.T.T.J. Singh, Prevalence of Zinc Deficiency and the Effect of Zinc Supplementation on the Prevention of Acute Respiratory Infections, 21(6) (2020) 371. ## [113] I. Wessels, H. Haase, G. Engelhardt, L. Rink, P.J.T.J.o.n.b. Uciechowski, Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms, 24(1) (2013) 289-297. ## [114] E. Rosenkranz, C.H. Metz, M. Maywald, R.D. Hilgers, I. Weßels, T. Senff, H. Haase, M. Jäger, M. Ott, R.J.M.n. Aspinall, f. research, Zinc supplementation induces regulatory T cells by inhibition of Sirt‐1 deacety-lase in mixed lymphocyte cultures, 60(3) (2016) 661-671. ## [115] C. Wu, X. Chen, Y. Cai, X. Zhou, S. Xu, H. Huang, L. Zhang, X. Zhou, C. Du, Y.J.J.i.m. Zhang, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, 180(7) (2020) 934-943. ## [116] A. Tsatsakis, N.V. Tyshko, A.O. Docea, S.I. Shestakova, Y.S. Sidorova, N.A. Petrov, O. Zla-tian, M. Mach, T. Hartung, V.A.J.T.l. Tutelyan, The effect of chronic vitamin deficiency and long term very low dose exposure to 6 pesticides mixture on neurological outcomes–a real-life risk simulation approach, 315 (2019) 96-106. ## [117] M.G. Skalnaya, A.V.J.T.P.H.o.T.S.U. Skalny, Essential trace elements in human health: a physician’s view, (2018) 224. ## [118] M.S.J.C. Razzaque, s.b. journal, COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection, (2021). ## [119] R.O. Suara, J.E.J.A.a. Crowe Jr, chemotherapy, Effect of zinc salts on respiratory syncytial virus replication, 48(3) (2004) 783-790. ## [120] J. Shang, Y. Wan, C. Luo, G. Ye, Q. Geng, A. Auerbach, F.J.P.o.t.N.A.o.S. Li, Cell entry mechanisms of SARS-CoV-2, 117(21) (2020) 11727-11734. ## [121] V.B. Patel, J.-C. Zhong, M.B. Grant, G.Y.J.C.r. Oudit, Role of the ACE2/angiotensin 1–7 axis of the renin–angiotensin system in heart failure, 118(8) (2016) 1313-1326. ## [122] M.C. Lee, Y.-K. Chen, Y.-J. Hsu, B.-R.J.b. Lin, Zinc supplement augments the suppressive ef-fects of repurposed drugs of NF-kappa B inhibitor on ACE2 expression in human lung cell lines in vitro, (2021). ## [123] P. Carlucci, T. Ahuja, C.M. Petrilli, H. Rajagopalan, S. Jones, J.J.M. Rahimian, Hydroxychlo-roquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients, (2020). ## [124] Y.-K. Chen, T.-T. Huang, C.-W. Chang, M.-C. Lee, B.-R. Lin, Y.-P. Lu, Y.-J. Hsu, C.-Y.J.b. Chuang, Azithromycin Plus Zinc Sulfate Rapidly and Synergistically Suppresses IκBα-Mediated In Vitro Human Airway Cell ACE2 Expression for SARS-CoV-2 Entry, (2021). ## [125] M. Rezaei, S.M. Mirkazemi, S.J.J.o.S. Alamolhoda, N. Magnetism, The Role of PVA Surfactant on Magnetic Properties of MnFe2O4 Nanoparticles Synthesized by Sol-Gel Hydrothermal Method, (2021) 1-12. ## [126] H. Rashidza-deh, H. Danafar, H. Rahimi, F. Mozafari, M. Salehiabar, M.A. Rahmati, S. Rahamooz-Haghighi, N. Mousaza-deh, A. Mohammadi, Y.N.J.N. Ertas, Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives, 16(6) (2021) 497-516. ## [127] F. Sharifianjazi, M. Irani, A. Esmaeilkhanian, L. Bazli, M.S. Asl, H.W. Jang, S.Y. Kim, S. Ramakrishna, M. Shokouhimehr, R.S. Varma, Polymer incorporated magnetic nanoparticles: Applications for magnetore-sponsive targeted drug delivery, Materials Science and Engineering: B 272 (2021) 115358. ## [128] S. Jindal, P. Gopinath, Nanotechnology based approaches for combatting COVID-19 viral infection, Nano Express 1(2) (2020) 022003. ## [129] H.-W. Chen, Z.-S. Fang, Y.-T. Chen, Y.-I. Chen, B.-Y. Yao, J.-Y. Cheng, C.-Y. Chien, Y.-C. Chang, C.-M.J. Hu, Targeting and Enrichment of Viral Pathogen by Cell Membrane Cloaked Magnetic Nanoparticles for Enhanced Detection, ACS applied materials and interfaces 9(46) (2017) 39953-39961. ## [130] J. Yang, Inhibition of SARS-CoV-2 Replication by Acidizing and RNA Lyase-Modified Carbon Nano-tubes Combined with Photodynamic Thermal Effect, J Explor Res Pharmacol 5(2) (2020) 18-23. ## [131] F. Niazvand, P.R. Wagh, E. Khazraei, M. Borzouyan Dastjerdi, C. Patil, I.A. Najar, Application of carbon allo-tropes composites for targeted cancer therapy drugs: A review, Journal of Composites and Compounds 3(7) (2021) 140-151. ## [132] Y.-T. Yeh, Y. Tang, A. Sebastian, A. Dasgupta, N. Perea-Lopez, I. Albert, H. Lu, M. Terrones, S.-Y. Zheng, Tunable and label-free virus enrichment for ultrasensitive virus detection using carbon nanotube arrays, 2(10) (2016) J. Science Advances. ## [133] I. Tajzad, E. Ghasali, Production methods of CNT-reinforced Al matrix composites: a review, Journal of Composites and Compounds 2(2) (2020) 1-9. ## [134] R.L. Pinals, F. Ledesma, D. Yang, N. Navarro, S. Jeong, J.E. Pak, L. Kuo, Y.-C. Chuang, Y.-W. Cheng, H.-Y. Sun, M.P. Landry, Rapid SARS-CoV-2 Spike Protein Detection by Carbon Nanotube-Based Near-Infrared Nanosensors, Nano Letters 21(5) (2021) 2272-2280. ## [135] S. Mohammadi, M. Heidarizadeh, M. Entesari, A. Esmailpour, M. Esmailpour, R. Moradi, N. Sakhaee, E. Doustkhah, In silico investigation on the inhibiting role of nicotine/caffeine by blocking the S protein of SARS-CoV-2 versus ACE2 receptor, Microor-ganisms 8(10) (2020) 1600. ## [136] M. Hussain, N. Jabeen, F. Raza, S. Shabbir, A.A. Baig, A. Amanullah, B. Aziz, Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein, Journal of medical virology 92(9) (2020) 1580-1586. ## [137] M.A. Alam, M.H. Asoushe, P. Pourhakkak, L. Gritsch, A. Alipour, S. Mohammadi, Preparation of bioactive polymer-based composite by different techniques and application in tissue engineering: A review, Journal of Composites and Compounds 3(8) (2021) 194-205. ## [138] B.S. Miller, L. Bezinge, H.D. Gliddon, D. Huang, G. Dold, E.R. Gray, J. Heaney, P.J. Dobson, E. Nastou-li, J.J.L. Morton, R.A. McKendry, Spin-enhanced nanodiamond biosensing for ultrasensitive diagnostics, Na-ture 587(7835) (2020) 588-593. ## [139] M. Nasrollahzadeh, M. Sajjadi, G.J. Soufi, S. Iravani, R.S. Varma, Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Corona-viruses, 10(6) (2020) 1072. ## [140] A. Stein, Z. Wang, M.A. Fierke, Functionalization of Porous Carbon Ma-terials with Designed Pore Architecture, 21(3) (2009) 265-293. ## [141] T. Matsushita, H. Suzuki, N. Shirasa-ki, Y. Matsui, K. Ohno, Adsorptive virus removal with super-powdered activated carbon, Separation and Puri-fication Technology 107 (2013) 79-84. ## [142] Y. Rasmi, K.S. Saloua, M. Nemati, J.R. Choi, Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment, 11(7) (2021) 1788. ## [143] Y. Zamani, A. Zareein, L. Bazli, R. NasrAzadani, B. Pasha Mahammod, S. Nasibi, A. Modarresi Chahardehi, Nanodiamond-containing composites for tissue sca?olds and surgical implants: A review, Journal of Compo-sites and Compounds 2(5) (2020) 215-227. ## [144] M.A. Hasan, A. Carmel Mary Esther, A. Dey, A.K. Mukhopadhyay, A review on coronavirus survivability on material’s surfaces: present research scenarios, technologies and future directions, Surface Engineering 36(12) (2020) 1226-1239. ## [145] V. Vamvakaki, N.A. Chaniotakis, Carbon nanostructures as transducers in biosensors, Sensors and Actuators B: Chemical 126(1) (2007) 193-197. ## [146] F. Valentini, M. Carbone, G. Palleschi, Carbon nanostructured materials for applications in nano-medicine, cultural heritage, and electrochemical biosensors, Analytical and Bioanalytical Chemistry 405(2) (2013) 451-465. ## [147] Z.J.N.-m.l. Zhu, An overview of carbon nanotubes and graphene for biosensing applications, 9(3) (2017) 1-24. ## [148] K.R. Ratinac, W. Yang, J.J. Gooding, P. Thordarson, F.J.E. Braet, Graphene and related materials in electrochemical sensing, 23(4) (2011) 803-826. ## [149] H. Ma, D. Wu, Z. Cui, Y. Li, Y. Zhang, B. Du, Q.J.A.L. Wei, Graphene-based optical and electrochemical biosen-sors: a review, 46(1) (2013) 1-17. ## [150] E. Asadi, A. Fassadi Chimeh, S. Hosseini, S. Rahimi, B. Sarkhosh, L. Bazli, R. Bashiri, A.H. Vakili Tahmorsati, A review of clinical applications of graphene quantum dot-based composites, Journal of Composites and Compounds 1(1) (2019) 31-40. ## [151] G. Wu, M. Meyyappan, K.W.C.J.S. Lai, Simulation of graphene field-effect transistor biosensors for bacterial detection, 18(6) (2018) 1715. ## [152] R. Abedini-Nassab, N. Mahdaviyan, Recent Patents and Advances on Nanotechnologies against Coronavirus, Recent Patents on Nanotechnology, 15(4) (2021) 322-330. ## [153] R. Antiochia, Nanobiosen-sors as new diagnostic tools for SARS, MERS and COVID-19: from past to perspectives, Microchimica Acta 187(12) (2020) 1-13. ## [154] J.E. Contreras-Naranjo, O.J.B. Aguilar, Suppressing non-specific binding of proteins onto electrode surfaces in the development of electrochemical immunosensors, 9(1) (2019) 15. ## [155] V.J.N. Uskoković, Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?, 15(17) (2020) 1719-1734. ## [156] A. Kazemzadeh, M.A. Meshkat, H. Kazemzadeh, M. Moradi, R. Bahrami, R. Pouriamanesh, Preparation of graphene nanolayers through surfactant-assisted pure shear milling method, Journal of Composites and Compounds 1(1) (2019) 22-26. ## [157] R. Gupta, P. Sagar, N. Priyadarshi, S. Kaul, R. Sandhir, V. Rishi, N.K.J.F.i.N. Singhal, Nanotechnology-based approaches for the detection of SARS-CoV-2, 2 (2020) 6. ## [158] X. Du, R. Xiao, H. Fu, Z. Yuan, W. Zhang, L. Yin, C. He, C. Li, J. Zhou, G.J.M.S. Liu, E. C, Hypericin-loaded graphene oxide protects ducks against a novel duck reovirus, 105 (2019) 110052. ## [159] O. Akhavan, M. Choobtashani, E.J.T.J.o.P.C.C. Ghaderi, Protein degra-dation and RNA efflux of viruses photocatalyzed by graphene–tungsten oxide composite under visible light irradiation, 116(17) (2012) 9653-9659. ## [160] S. Ye, K. Shao, Z. Li, N. Guo, Y. Zuo, Q. Li, Z. Lu, L. Chen, Q. He, H.J.A.a.m. Han, interfaces, Antiviral activity of graphene oxide: how sharp edged structure and charge matter, 7(38) (2015) 21571-21579. ## [161] Z. Song, X. Wang, G. Zhu, Q. Nian, H. Zhou, D. Yang, C. Qin, R.J.S. Tang, Virus capture and destruction by label‐free graphene oxide for detection and disinfection applica-tions, 11(9-10) (2015) 1171-1176. ## [162] G. Seo, G. Lee, M.J. Kim, S.-H. Baek, M. Choi, K.B. Ku, C.-S. Lee, S. Jun, D. Park, H.G.J.A.n. Kim, Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor, 14(4) (2020) 5135-5142. ## [163] D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R.J.N.n. Langer, Nanocarriers as an emerging platform for cancer therapy, 2(12) (2007) 751-760. ## [164] S. Manivannan, K.J.A.o.c. Ponnuchamy, Quantum dots as a promising agent to combat COVID‐19, 34(10) (2020) e5887. ## [165] S. Nikazar, V.S. Sivasanka-rapillai, A. Rahdar, S. Gasmi, P. Anumol, M.S.J.B.r. Shanavas, Revisiting the cytotoxicity of quantum dots: An in-depth overview, 12(3) (2020) 703-718. ## [166] H. Ashiba, Y. Sugiyama, X. Wang, H. Shirato, K. Higo-Moriguchi, K. Taniguchi, Y. Ohki, M.J.B. Fujimaki, Bioelectronics, Detection of norovirus virus-like particles using a surface plasmon resonance-assisted fluoroimmunosensor optimized for quantum dot fluorescent la-bels, 93 (2017) 260-266. ## [167] C. Roh, S.K.J.J.o.C.T. Jo, Biotechnology, Quantitative and sensitive detec-tion of SARS coronavirus nucleocapsid protein using quantum dots‐conjugated RNA aptamer on chip, 86(12) (2011) 1475-1479. ## [168] S.-L. Liu, Z.-G. Wang, H.-Y. Xie, A.-A. Liu, D.C. Lamb, D.-W.J.C.r. Pang, Sin-gle-virus tracking: from imaging methodologies to virological applications, 120(3) (2020) 1936-1979. ## [169] Á. Serrano-Aroca, K. Takayama, A. Tuñón-Molina, M. Seyran, S.S. Hassan, P. Pal Choudhury, V.N. Uversky, K. Lundstrom, P. Adadi, G.J.A.n. Palù, Carbon-based nanomaterials: promising antiviral agents to combat COVID-19 in the microbial-resistant era, (2021). ## [170] A. Łoczechin, K. Séron, A. Barras, E. Gio-vanelli, S. Belouzard, Y.-T. Chen, N. Metzler-Nolte, R. Boukherroub, J. Dubuisson, S.J.A.a.m. Szunerits, in-terfaces, Functional carbon quantum dots as medical countermeasures to human coronavirus, 11(46) (2019) 42964-42974. ## [171] S.R. Ahmed, S.W. Kang, S. Oh, J. Lee, S.J.H. Neethirajan, Chiral zirconium quantum dots: a new class of nanocrystals for optical detection of coronavirus, 4(8) (2018) e00766. ## [172] S.R. Ah-med, É. Nagy, S.J.R.a. Neethirajan, Self-assembled star-shaped chiroplasmonic gold nanoparticles for an ul-trasensitive chiro-immunosensor for viruses, 7(65) (2017) 40849-40857. ## [173] T. Du, J. Liang, N. Dong, J. Lu, Y. Fu, L. Fang, S. Xiao, H.J.A.a.m. Han, interfaces, Glutathione-capped Ag2S nanoclusters inhibit corona-virus proliferation through blockage of viral RNA synthesis and budding, 10(5) (2018) 4369-4378. ## [174] I.A. Khalil, M.A. Younis, S. Kimura, H.J.B. Harashima, P. Bulletin, Lipid nanoparticles for cell-specific in vivo targeted delivery of nucleic acids, 43(4) (2020) 584-595. ## [175] A. Walls, Y.J.S. Park, function,, a.o.t.S.C.s.g. Cell, J, Tortorici MA, Wall A, McGuire AT, Veesler D, 181(2) (2020) 281-292. ## [176] J. Qi, J. Zhuang, Y. Lu, X. Dong, W. Zhao, W.J.D.d.t. Wu, In vivo fate of lipid-based nanoparticles, 22(1) (2017) 166-172. ## [177] I.Z. Sadiq, F.S. Abubakar, B.I.J.J.o.T.U.f.S. Dan-Iya, Role of nanoparticles in tackling COVID-19 pandemic: a bio-nanomedical approach, 15(1) (2021) 198-207. ## [178] C.Y. Yong, H.K. Ong, S.K. Yeap, K.L. Ho, W.S.J.F.i.m. Tan, Recent advances in the vaccine development against Middle East respiratory syn-drome-coronavirus, 10 (2019) 1781. ## [179] S. Talaei, H. Mellatyar, S. Mohammadi, Y. Panahi, P. Kianpour, A. Akbarzadeh, N.J.E.J.O.H. Zarghami, Nanotechnology and COVID-19: Potential Application for Treatment, 1. ## [180] M. Alavi, K. Asare-Addo, A.J.B. Nokhodchi, Lectin Protein as a Promising Component to Func-tionalize Micelles, Liposomes and Lipid NPs against Coronavirus, 8(12) (2020) 580. ## [181] T.T. Tai, T.J. Wu, H.D. Wu, Y.C. Tsai, H.T. Wang, A.M. Wang, S.F. Shih, Y.C.J.C. Chen, T. Science, A Strategy to Treat COVID‐19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Phar-macokinetic Study, 14(1) (2021) 132-136. ## [182] I. Feliciello, A.J.H.v. Procino, immunotherapeutics, The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses, 16(10) (2020) 2373-2373. ## [183] G. Li, R. Hu, X.J.H.R. Zhang, Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension, 43(6) (2020) 588-590. ## [184] Z. Abpeikar, R. Mohseni, M.J.T. Safaei, E. Chemistry, The multifunctional nano-immunoliposome design: hypothesis on a therapeutic approach for COVID-19, 103(1) (2021) 118-125. ## [185] A.A. Khan, K.S. Allemailem, S.A. Almatroodi, A. Almatroudi, A.H.J.B. Rahmani, Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications, 10(4) (2020) 1-15. ## [186] R. Jinyu, C. Yi, W. Bin, C. Hong, Z. Ying, S.J.C.J.o.I.T. Zhong, W.M.o.L. Diseases, Study of the Targeting Therapy on Virus Hepatitis: Preparation and Clinical Observation of the Liposomal Drugs for Anti-HBV [J], 1 (1997). ## [187] V. Alimardani, S.S. Abolmaali, A.M.J.J.o.N. Tamaddon, Recent advances on nanotechnology-based strategies for prevention, di-agnosis, and treatment of coronavirus infections, 2021 (2021). ## [188] Q.S. Sun, J.L. Zhang, D.Q. Han, Y.B. Yang, L. Zhu, L. Yu, Characterization and immunological evaluation of chitosan nanoparticles as adjuvants for bovine coronavirus N protein, Applied Mechanics and Materials, Trans Tech Publ, 2012, pp. 113-120. ## [189] T. Nochi, Y. Yuki, H. Takahashi, S.-i. Sawada, M. Mejima, T. Kohda, N. Harada, I.G. Kong, A. Sato, N.J.N.m. Kataoka, Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines, 9(7) (2010) 572-578. ## [190] C. Lee, A. Hwang, L. Jose, J.H. Park, S. Jang, J.K. Song, Y. Kim, Y. Cho, H.B. Jeon, J.-O.J.J.o.I. Jin, E. Chemistry, RAFT/PISA based Ni-NTA polymeric particles for virus-mimetic influenza vaccines, 86 (2020) 35-38. ## [191] C.P. Haycook, J.A. Balsamo, E.B. Glass, C.H. Williams, C.C. Hong, A.S. Major, T.D.J.I.j.o.n. Giorgio, PEGylated PLGA nanoparticle delivery of eggmanone for T cell modulation: ap-plications in rheumatic autoimmunity, 15 (2020) 1215. ## [192] S.A. Cohen, P.S. Kingma, J. Whitsett, R. Goldbart, T. Traitel, J.J.I.J.o.P. Kost, SP-D loaded PLGA nanoparticles as drug delivery system for prevention and treatment of premature infant’s lung diseases, 585 (2020) 119387. ## [193] S. Amjadi, H. Hamishehkar, M.J.M.S. Ghorbani, E. C, A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: A strategy for enhancing the therapeutic efficacy of chemotherapy, 97 (2019) 833-841. ## [194] N. Sankarakumar, Y.W.J.J.o.M.C.B. Tong, Preventing viral infections with polymeric virus catchers: a novel nanotechnological approach to anti-viral therapy, 1(15) (2013) 2031-2037. ## [195] L.C.W. Lin, C.Y. Huang, B.Y. Yao, J.C. Lin, A. Agrawal, A. Algaissi, B.H. Peng, Y.H. Liu, P.H. Huang, R.H.J.A.f.m. Juang, Viromimet-ic STING agonist‐loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus, 29(28) (2019) 1807616. ## [196] J.L. McGill, S.M. Kelly, P. Kumar, S. Speckhart, S.L. Haughney, J. Henningson, B. Narasimhan, R.E.J.S.r. Sacco, Efficacy of mucosal polyanhy-dride nanovaccine against respiratory syncytial virus infection in the neonatal calf, 8(1) (2018) 1-15. ## [197] J.R. Francica, G.M. Lynn, R. Laga, M.G. Joyce, T.J. Ruckwardt, K.M. Morabito, M. Chen, R. Chaudhuri, B. Zhang, M.J.B.c. Sastry, Thermoresponsive polymer nanoparticles co-deliver RSV F trimers with a TLR-7/8 adjuvant, 27(10) (2016) 2372-2385. ## [198] G.M. Lynn, R. Laga, P.A. Darrah, A.S. Ishizuka, A.J. Balaci, A.E. Dulcey, M. Pechar, R. Pola, M.Y. Gerner, A.J.N.b. Yamamoto, In vivo characterization of the physicochemi-cal properties of polymer-linked TLR agonists that enhance vaccine immunogenicity, 33(11) (2015) 1201-1210. ## [199] M. Dabaghian, A.M. Latifi, M. Tebianian, H. NajmiNejad, S.M.J.V. Ebrahimi, Nasal vaccina-tion with r4M2e. HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model, 36(20) (2018) 2886-2895. ## [200] S. Dhakal, S. Renu, S. Ghimire, Y. Shaan Lakshmanappa, B.T. Hogshead, N. Feliciano-Ruiz, F. Lu, H. HogenEsch, S. Krakowka, C.W.J.F.i.i. Lee, Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is im-proved by chitosan nanoparticle delivery in pigs, 9 (2018) 934. ## [201] C. Sawaengsak, Y. Mori, K. Yamanishi, A. Mitrevej, N.J.A.P. Sinchaipanid, Chitosan nanoparticle encapsulated hemagglutinin-split influ-enza virus mucosal vaccine, 15(2) (2014) 317-325. ## [202] Q. Liu, X. Zheng, C. Zhang, X. Shao, X. Zhang, Q. Zhang, X.J.J.o.m.v. Jiang, Conjugating influenza a (H1N1) antigen to n‐trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration, 87(11) (2015) 1807-1815. ## [203] S. Okamoto, M. Matsuura, T. Akagi, M. Akashi, T. Tanimoto, T. Ishikawa, M. Takahashi, K. Yamanishi, Y.J.V. Mori, Poly (γ-glutamic acid) nano-particles combined with mucosal influenza virus he-magglutinin vaccine protects against influenza virus infection in mice, 27(42) (2009) 5896-5905. ## [204] S. Dhakal, J. Hiremath, K. Bondra, Y.S. Lakshmanappa, D.-L. Shyu, K. Ouyang, K.-i. Kang, B. Binjawadagi, J. Goodman, K.J.J.o.C.R. Tabynov, Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs, 247 (2017) 194-205.